For: | Miteva D, Peshevska-Sekulovska M, Snegarova V, Batselova H, Alexandrova R, Velikova T. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic. World J Virol 2022; 11(5): 221-236 [PMID: 36188733 DOI: 10.5501/wjv.v11.i5.221] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v11/i5/221.htm |
Number | Citing Articles |
1 |
Michael Yee-Tak Chow, Jenny Ka Wing Lam. Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines. AAPS Introductions in the Pharmaceutical Sciences 2023; 8: 123 doi: 10.1007/978-3-031-47567-2_6
|
2 |
Brittany A. Comunale, Robin J. Larson, Yea-Jen Hsu, Erin Jackson-Ward, Chisom Azodoh, Aditi Singh, Lilly D. Engineer. Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination. Vaccines 2024; 12(3): 219 doi: 10.3390/vaccines12030219
|
3 |
Ekaterina R. Korchevaya, Anastasiia V. Gracheva, Ilya N. Dyakov, Зверев V. Zverev, Evgeny B. Faizuloev. Live attenuated COVID-19 vaccines: approaches to development and prospects for clinical use. Journal of microbiology, epidemiology and immunobiology 2023; 100(3): 225 doi: 10.36233/0372-9311-404
|
4 |
Junwei Gao, Can Cao, Mingfei Shi, Shihao Hong, Shijie Guo, Jing Li, Tengxiao Liang, Ping Song, Ruodan Xu, Ning Li. Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion. Phytomedicine 2023; 118: 154942 doi: 10.1016/j.phymed.2023.154942
|
5 |
Mila Biswas, Md Nurunnabi, Zehedina Khatun. Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity. ACS Applied Bio Materials 2024; 7(8): 5037 doi: 10.1021/acsabm.4c00395
|
6 |
Salvatore Calogero Gaglio, Massimiliano Perduca, Donato Zipeto, Giuseppe Bardi. Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization. Vaccines 2023; 11(8): 1333 doi: 10.3390/vaccines11081333
|
7 |
Jean-Marc Cavaillon, Benjamin G. Chousterman, Tomasz Skirecki. Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19. Journal of Intensive Medicine 2024; 4(3): 326 doi: 10.1016/j.jointm.2024.01.001
|
8 |
Nur Farhanah Arshad, Fariza Juliana Nordin, Lian Chee Foong, Lionel Lian Aun In, Michelle Yee Mun Teo, Dhanusha Yesudhas. Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants. PLOS ONE 2024; 19(8): e0306111 doi: 10.1371/journal.pone.0306111
|
9 |
Chiara Gai, Margherita Alba Carlotta Pomatto, Maria Chiara Deregibus, Marco Dieci, Alessandro Piga, Giovanni Camussi. Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery. Vaccines 2024; 12(2): 200 doi: 10.3390/vaccines12020200
|
10 |
Martin Joseph Lett, Fabian Otte, David Hauser, Jacob Schön, Enja Tatjana Kipfer, Donata Hoffmann, Nico J. Halwe, Angele Breithaupt, Lorenz Ulrich, Tobias Britzke, Jana Kochmann, Björn Corleis, Yuepeng Zhang, Lorena Urda, Vladimir Cmiljanovic, Christopher Lang, Martin Beer, Christian Mittelholzer, Thomas Klimkait. High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters. npj Vaccines 2024; 9(1) doi: 10.1038/s41541-024-00992-z
|
11 |
In-Chan Hwang, Robie Vasquez, Ji Hoon Song, Lars Engstrand, Valerie Diane Valeriano, Dae-Kyung Kang. Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 spike epitopes in mice. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1242681
|
12 |
Yoanna Slabakova, Stavros Gerasoudis, Dimitrina Miteva, Monika Peshevska-Sekulovska, Hristiana Batselova, Violeta Snegarova, Georgi V. Vasilev, Georgi H. Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, Latchezar Tomov, Tsvetelina Velikova. SARS-CoV-2 Variant-Specific Gastrointestinal Symptoms of COVID-19: 2023 Update. Gastroenterology Insights 2023; 14(4): 431 doi: 10.3390/gastroent14040032
|
13 |
Zabardast T. Buriev, Shukhrat E. Shermatov, Dilshod E. Usmanov, Mukhammadjon K. Mirzakhmedov, Khurshida A. Ubaydullaeva, Venera S. Kamburova, Bakhtiyor K. Rakhmanov, Mirzakamol S. Ayubov, Adkham N. Abdullaev, Jakhongir B. Eshmurzaev, Behzod O. Mamajonov, Akmal A. Tulanov, Adolat A. Ismailova, Tatyana A. Petrova, Ramazan J. Rozumbetov, Tamara U. Aripova, Muzaffar I. Muminov, Khusnora Y. Ermatova, Dilbar A. Dalimova, Shahlo U. Turdikulova, Abdusattor Abdukarimov, Ibrokhim Y. Abdurakhmonov. Tomato-made edible COVID-19 vaccine TOMAVAC induces neutralizing IgGs in the blood sera of mice and humans. Frontiers in Nutrition 2024; 10 doi: 10.3389/fnut.2023.1275307
|
14 |
Antonio Toniolo, Giuseppe Maccari, Giovanni Camussi. mRNA Technology and Mucosal Immunization. Vaccines 2024; 12(6): 670 doi: 10.3390/vaccines12060670
|
15 |
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi V. Vasilev, Luchesar Tomov, Tsvetelina Velikova. The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice. Vaccines 2023; 11(7): 1181 doi: 10.3390/vaccines11071181
|
16 |
Ileana García-Silva, Dania O Govea-Alonso, Sergio Rosales-Mendoza. Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity. Expert Opinion on Biological Therapy 2023; 23(2): 207 doi: 10.1080/14712598.2022.2156284
|
17 |
Yufeng Song, Frances Mehl, Steven L. Zeichner. Vaccine Strategies to Elicit Mucosal Immunity. Vaccines 2024; 12(2): 191 doi: 10.3390/vaccines12020191
|
18 |
Anubhuti Sood, Sreevatsan Raghavan, Deepika Mishra, Harsh Priya. Effects of post-COVID-19 vaccination in oral cavity: a systematic review. Evidence-Based Dentistry 2024; 25(3): 168 doi: 10.1038/s41432-024-01014-6
|
19 |
Evgeny B. Faizuloev, Anastasiia V. Gracheva, Ekaterina R. Korchevaya, Yulia I. Ammour, Daria I. Smirnova, Darya M. Khokhlova, Andrey O. Drokov, Andrey A. Pankratov, Galina V. Trunova, Varvara A. Khokhlova, Maria S. Vorontsova, Irina A. Leneva, Oksana A. Svitich, Vitaly V. Zverev. Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern. Journal of microbiology, epidemiology and immunobiology 2024; 101(1): 36 doi: 10.36233/0372-9311-496
|